Advanced Search
MyIDEAS: Login

Medizinisch-technische Innovationen in der Gesundheitswirtschaft am Beispiel der Neuen Untersuchungs- und Behandlungsmethoden (NUB)

Contents:

Author Info

  • von Bandemer, Stephan
  • Merkel, Sebastian
  • Nimako-Doffour, Anna
Registered author(s):

    Abstract

    Medizinisch technische Innovationen in der Gesundheitswirtschaft benötigen Verfahren zur Refinanzierung neuartiger Leistungen. Ein wichtiges Instrument bildet das Verfahren für Neue Untersuchungs- und Behandlungsmethoden (NUB). Neben dem möglichen Fortschritt in der Versorgung wird allerdings befürchtet, dass durch entsprechende Innovationen die Kosten stark ansteigen und eine undifferenzierte Verbreitung erfolgt. In den vergangenen Jahren wurden aber nur sehr wenige NUB-Neuanträge anerkannt (Status 1). Auch die Umsetzung neuer Untersuchungs- und Behandlungsmethoden in die Versorgungspraxis erfolgt in den meisten Fällen sehr langsam. Neue Untersuchungs- und Behandlungsmethoden werden in der Versorgungsrealität überwiegend in spezialisierten Zentren angewendet. Insgesamt trägt das NUB-Verfahren dazu bei, dass Innovationen in einem sehr begrenzten Maß Zugang zur Refinanzierung im Rahmen des G-DGR Systems erhalten. --

    Download Info

    If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
    File URL: http://econstor.eu/bitstream/10419/57198/1/690187505.pdf
    Download Restriction: no

    Bibliographic Info

    Paper provided by Institut Arbeit und Technik (IAT), Westfälische Hochschule, University of Applied Sciences in its series Forschung Aktuell with number 04/2012.

    as in new window
    Length:
    Date of creation: 2012
    Date of revision:
    Handle: RePEc:zbw:iatfor:042012

    Contact details of provider:
    Web page: http://www.iat.eu/
    More information through EDIRC

    Related research

    Keywords:

    This paper has been announced in the following NEP Reports:

    References

    References listed on IDEAS
    Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
    as in new window
    1. Morgan, Steve & Grootendorst, Paul & Lexchin, Joel & Cunningham, Colleen & Greyson, Devon, 2011. "The cost of drug development: A systematic review," Health Policy, Elsevier, vol. 100(1), pages 4-17, April.
    Full references (including those not matched with items on IDEAS)

    Citations

    Lists

    This item is not listed on Wikipedia, on a reading list or among the top items on IDEAS.

    Statistics

    Access and download statistics

    Corrections

    When requesting a correction, please mention this item's handle: RePEc:zbw:iatfor:042012

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (ZBW - German National Library of Economics).

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If references are entirely missing, you can add them using this form.

    If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.